Ac-225-PSMA-617 apparently extends survival of very late-stage patients: an update

Posted on December 23, 2016 by Sitemaster

The nuclear medicine group at the University of Heidelberg in Germany recently reported a complete response in two patients treated with Ac-225-PSMA-617 (see this link). … READ MORE …

Filed under: Drugs in development, Management, Treatment | Tagged: , , , | 6 Comments »

The language of denial of access to high-quality prostate cancer care today

Posted on October 24, 2016 by Sitemaster

If you look at the corporate web site for eviCore Healthcare, the company describes itself as follows: … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: , , , | 6 Comments »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives